Product Images Deferasirox

This text provides a chart showing the change in liver iron content (LIC) and serum ferritin with different doses of deferasirox, a medication used to reduce iron overload in the body. The chart shows the doses in mg/kg/day and the corresponding changes in LIC and serum ferritin in mg/L. These measures are important in assessing the effectiveness of deferasirox in managing iron overload.*

Deferasirox is a medication that comes in tablet form and is only available with a prescription. Each film-coated tablet contains 20mg of Defarasirox. This medication guide should be provided to each patient with their prescription. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), and excursions up to 15°C to 30°C (50°F to 85°F) are permitted. The manufacturer is Cipa Lid, located in Kurkumbh India, and the product is manufactured for Cipla USA, Inc., located at 10 Independence Boulevard, Suite 300, Warren, NJ 07050. Batch overprinting will be done after commercial packing.*

Deferasirox is a prescription tablet medication used to treat excess iron in the body. Each film-coated tablet contains 180mg Deferasirox. The medication guide should be provided to each patient with a pack of 30 tablets. The tablets should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F) and protected from moisture. Manufactured by Cipla Ltd. in India and Cipla USA, Inc. in the USA. This information is valid as of March 2020.*

Deferasirox is a prescription medication available in tablet form, sold in 30 tablet bottles by Cipla. A Medication Guide is provided with each bottle. The drug's NDC code is 69097-393-02. The instructions for storage details the temperature and humidity conditions required for safekeeping the medication. The remaining text is not legible.*